GGrantIndex
← Leaderboards

Boyi Gan

University Of Tx Md Anderson Can Ctr

Google Scholar ↗PubMed ↗ORCID ↗
$13,125,533
Attributed
$13,247,099
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY2014–25
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,966,439 · 10

By mechanism

R01$10,648,832 · 5
U54$8,317,607 · 5

Top collaborators

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Tumor”

Research focus

TumorMediatingCancer TherapyMalignant NeoplasmsCancer CellTumor SuppressionPathway InteractionsInnovationNovel TherapeuticsResistanceMalignant Neoplasm Of LungCell DeathTranslatingLinkPre-ClinicalNovel Therapeutic InterventionTumor GrowthRadiation TherapyIronMutantMouse ModelCellsCancer PatientMedical

Grant awards (46)

Acquired Resistance to Therapy and Iron (ARTI) Center$1,356,911
U54 · FY2025 · CA · contact PI
Targeting ferroptosis in cancer therapy$493,996
R01 · FY2025 · CA · contact PI
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation$393,304
R01 · FY2025 · CA · contact PI
Administrative Core$314,936
U54 · FY2025 · CA · contact PI
Ferroptosis resistance as a key driver in acquired radiation resistance$279,167
U54 · FY2025 · CA · contact PI
Acquired Resistance to Therapy and Iron (ARTI) Center$1,289,134
U54 · FY2024 · CA · contact PI
Targeting ferroptosis in cancer therapy$469,297
R01 · FY2024 · CA · contact PI
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation$404,602
R01 · FY2024 · CA · contact PI
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation$373,639
R01 · FY2024 · CA · contact PI
Studying metabolic stress signaling in renal cancer$328,962
R01 · FY2024 · CA · contact PI
Administrative Core$302,642
U54 · FY2024 · CA · contact PI
Ferroptosis resistance as a key driver in acquired radiation resistance$265,598
U54 · FY2024 · CA · contact PI
Administrative Supplement: Investigating the role of iron redox dynamics in radiation resistance in esophageal cancer$177,125
U54 · FY2024 · CA · contact PI
Ferroptosis resistance as a key driver in acquired radiation resistance$177,125
U54 · FY2024 · CA · contact PI
Acquired Resistance to Therapy and Iron (ARTI) Center$1,356,931
U54 · FY2023 · CA · contact PI
Targeting ferroptosis in cancer therapy$493,996
R01 · FY2023 · CA · contact PI
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation$417,377
R01 · FY2023 · CA · contact PI
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation$385,437
R01 · FY2023 · CA · contact PI
Studying metabolic stress signaling in renal cancer$339,350
R01 · FY2023 · CA · contact PI
Administrative Core$313,499
U54 · FY2023 · CA · contact PI
Ferroptosis resistance as a key driver in acquired radiation resistance$279,166
U54 · FY2023 · CA · contact PI
Admin-Core-001$182,349
U54 · FY2023 · CA · contact PI
Administrative Supplement: Metabolic Alterations Associated with Acquired Resistance to Ferroptosis in Esophageal Cancer$182,349
U54 · FY2023 · CA · contact PI
Acquired Resistance to Therapy and Iron (ARTI) Center$1,356,890
U54 · FY2022 · CA · contact PI
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation$417,378
R01 · FY2022 · CA · contact PI
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation$385,437
R01 · FY2022 · CA · contact PI
Ferroptosis resistance as a key driver in acquired radiation resistance$339,834
U54 · FY2022 · CA · contact PI
Studying metabolic stress signaling in renal cancer$339,350
R01 · FY2022 · CA · contact PI
Administrative Core$143,951
U54 · FY2022 · CA · contact PI
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation$425,896
R01 · FY2021 · CA · contact PI
Targeting ferroptosis in radioresistance in lung cancer: mechanisms and preclinical translation$393,305
R01 · FY2021 · CA · contact PI
Studying metabolic stress signaling in renal cancer$346,275
R01 · FY2021 · CA · contact PI
Targeting SLC7A11-induced nutrient dependency in cancer: mechanisms and preclinical translation$425,895
R01 · FY2020 · CA · contact PI
Mechanistic studies of cancer cell adaptive response to PI3K/AKT inhibition$366,000
R01 · FY2020 · CA · contact PI
Studying metabolic stress signaling in renal cancer$346,275
R01 · FY2020 · CA · contact PI
Mechanistic studies of cancer cell adaptive response to PI3K/AKT inhibition$355,019
R01 · FY2019 · CA · contact PI
Studying metabolic stress signaling in renal cancer$322,040
R01 · FY2019 · CA · contact PI
Mechanistic studies of cancer cell adaptive response to PI3K/AKT inhibition$366,000
R01 · FY2018 · CA · contact PI
Studying metabolic stress signaling in renal cancer$332,000
R01 · FY2018 · CA · contact PI
Mechanistic studies of cancer cell adaptive response to PI3K/AKT inhibition$1
R01 · FY2017 · CA · contact PI
Studying metabolic stress signaling in renal cancer$1
R01 · FY2017 · CA · contact PI
Mechanistic studies of cancer cell adaptive response to PI3K/AKT inhibition$366,000
R01 · FY2016 · CA · contact PI
Studying metabolic stress signaling in renal cancer$332,000
R01 · FY2016 · CA · contact PI
Mechanistic studies of cancer cell adaptive response to PI3K/AKT inhibition$366,000
R01 · FY2015 · CA · contact PI
Studying metabolic stress signaling in renal cancer$332,000
R01 · FY2015 · CA · contact PI
Studying metabolic stress signaling in renal cancer$332,000
R01 · FY2014 · CA · contact PI